The correct way to take ceritinib/ceritinib
Ceritinib, as an ALK inhibitor, plays an important role in the treatment of ALK-positive non-small cell lung cancer (NSCLC). However, its efficacy is closely related to the way it is taken. The correct way of taking it can not only improve the drug absorption rate, but also reduce adverse reactions and improve the patient's treatment experience.
According to the latest clinical guidelines, the recommended dose of ceritinib is450 mg/day, which needs to be taken with food. This dose ensures efficacy while significantly reducing common gastrointestinal complaints such as nausea, vomiting and diarrhea. The 700 mg fasting regimen adopted early has been gradually phased out because it has many side effects and affects patients’ tolerance.

When taking medication, it is recommended that patients take it at the same time every day to maintain stable blood concentration. For example, if it is taken in the morning with breakfast, it should be taken at the same time each day to ensure the medication is most effective. At the same time, the capsule must be swallowed whole and must not be chewed, broken or dissolved to avoid affecting the release characteristics and absorption rate of the drug.
If the patient forgets to take the medicine, he should take it again according to the specific situation. If it is more than 12 hours before the next dose, you can take it as soon as possible; but if it is less than 12 hours, you should skip this dose and take the next dose directly according to the original plan. Do not take double doses to avoid increasing the risk of side effects.
During the medication, patients need to pay close attention to their own conditions, especially changes in liver function, blood sugar levels and blood pressure, because ceritinib may cause side effects such as elevated liver enzymes, hyperglycemia and hypertension. It is recommended that patients undergo regular blood tests and adjust their medication regimen under the guidance of a doctor. In addition, because this drug may interact with other drugs, such as proton pump inhibitors, H2 receptor antagonists, and certain antibiotics, patients should consult their doctor before taking other drugs to avoid potential drug interactions.
Reference materials:https://www.novartis.com/our-products/pipeline/ceritinib
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)